Alapis, after reading that article I sent the author Megan an e-mail telling her about Lympro. She responded to me an stated that she thought Lympro was a test to determine if a patient has AD after symptoms occur. I told her to go to AMBS web site and see where we are. She thanked me and said she would do that. Word has to get out if this company is going to survive. When an article doesn't mention AMBS we need to make the authors aware of our company instead of complaining we weren't mentioned.